Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Bibekanand Mallick

Has grant

Professor

National Institute of Technology Rourkela

No Info

Research Interests

Explore related searches

Professors in Cell Biology

Recent Grants

Grant: Close

Gomutra ark as a potent anti-cancer agent for the treatment of oral squamous cell carcinoma- Molecular mechanisms underlying its anti-cancer effect

Open Date: 2024-07-01

Close Date:

Grant: Close

Identification of new drug(s) for treating endometriosis-associated infertility by drug repurposing using signature microRNAs

Open Date: 2020-09-01

Close Date: 2023-09-01

Grant: Close

Genome-wide Profiling of PIWI-interacting RNAs (piRNAs) by Next-Generation Sequencing and investigating their role in Oral Squamous Cell Carcinoma

Open Date: 2018-08-20

Close Date: 2021-08-20

Grant: Close

Structural impact of SNPs on miRNA-mediated regulation and its implication in Cancer

Open Date: 2013-06-01

Close Date: 2016-06-01

Grant: Close

Decoding the dominant microRNA-mediated pluripotency networks in stem cells

Open Date: 2013-05-01

Close Date: 2016-05-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (1)

Akhilesh Mishra

Assistant Professor

National Institute of Technology Rourkela

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bibekanand Mallick

Research Interests

Explore related searches

Recent Grants

Articles (20)

Targeting EGFR in cancer using Terminalia arjuna: An integrated In Silico, molecular dynamics, experimental validation, and network pharmacology study

Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer

KLF5-mediated transcriptional activation of miR-203a inhibits EMT and increases cisplatin sensitivity by targeting SNAI2 in tongue cancer

microRNA-203a-3p sensitizes cisplatin through disruption of RAN-dependent RRM2 nuclear localization and mitochondrial stress readouts

Cisplatin disrupts OCT1-DNMT1-piRNA epigenetic regulatory axis to suppress GAB2-mediated aggressiveness in OSCC

Projection of epigenetic markers of Type 2 Diabetes Reveal Pancreatic Cancer Prognostic Tumour States

Strategies for dissecting the PIWI–piRNA–DNMT axis: Epigenetic silencing mechanisms underlying tumorigenesis

PLK1 inhibition by Shikonin attenuates oral cancer growth through β-catenin-mediated regulation of EMT and apoptosis.

Silent Guardians Gone Rogue: The Role of PIWI and piRNA in Malignant Transformation

A piRNA chemosensitizes doxorubicin in tongue squamous cell carcinoma by targeting FDFT1 and inhibiting the EIF3H/HIF1α/CYPOR axis

miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting

BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening

Unlocking the potential of signature-based drug repurposing for anticancer drug discovery

Correlating tissue and plasma‑specific piRNA changes to predict their possible role in pancreatic malignancy and chronic inflammation

Corrigendum to “Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumor explants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways” Pathol. - Res. Pract. 237 (2022) 154029

miR-185-5p rewires cisplatin resistance by restoring miR- 203a-3p expression via downregulation of SOX9

miR‐203a—A multifaceted regulator modulating cancer hallmarks and therapy response

LncRNA‐associated competing endogenous RNA network analysis uncovered key lncRNAs involved in temozolomide resistance and tumor recurrence of glioblastoma

FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma

TarpiD, a database of putative and validated targets of piRNAs

Collaborators (1)

Akhilesh Mishra

Make your next move.